Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
782 USD | +2.54% | +0.83% | +34.06% |
04:49pm | UK weight-loss drug price rivalry intensifies with Pharmacy2U mark-down | RE |
02:43pm | Eli Lilly Ethics/Compliance Chief Alonzo Weems to Retire | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.06% | 688B | |
+31.37% | 588B | |
-2.77% | 364B | |
+20.40% | 326B | |
+5.47% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.15% | 167B | |
+0.14% | 161B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Morgan Stanley Raises Price Target on Eli Lilly to $1,023 From $950 Amid 2024 Guidance Boost, Keeps Overweight Rating